Nicolas Hubacz: How Psychoactive Drugs Alter Spider Web Construction
Nicolas Hubacz, Research and Clinical Products Business Development Manager at Magstim, shared a post on LinkedIn:
“How Psychoactive Drugs Alter Spider Web Construction
In 1995, scientists explored how different drugs influence spider web construction to understand their impact on behavior and motor skills. This research was initiated due to a zoologist’s request to alter the time garden spiders build their webs. The team administered various psychoactive substances, such as amphetamine, mescaline, strychnine, LSD, and caffeine, observing changes in web size and shape rather than timing.
Low caffeine doses led to smaller webs with uneven radii, while higher doses resulted in even smaller, irregular designs. Each drug induced different effects: sleeping pills caused drowsiness and incomplete webs, Benzedrine created zigzag patterns, marijuana resulted in missing inner sections, and scopolamine disrupted directional sense.
The study highlighted how drugs affect spider behavior, offering insights into the broader impacts of psychoactive substances across species.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis